414804006: Product containing natalizumab (medicinal product)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorized by disposition\Product containing selective adhesion molecule inhibitor\Product containing alpha-4 integrin receptor antagonist\Product containing natalizumab
\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing natalizumab

\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing natalizumab

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

2531798017 Natalizumab (product) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
2535354010 Natalizumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3524446011 Product containing natalizumab (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3524447019 Product containing natalizumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3667763017 Natalizumab product en Synonym Inactive Entire term case insensitive SNOMED CT core module
3715878019 Natalizumab-containing product en Synonym Active Entire term case insensitive SNOMED CT core module
107839501000001118 Natalizumab en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing natalizumab	Is a	Product containing alpha-4 integrin receptor antagonist	true	Inferred relationship	Existential restriction modifier
Product containing natalizumab	Is a	Product containing monoclonal antibody	true	Inferred relationship	Existential restriction modifier
Product containing natalizumab	Has active ingredient	Natalizumab	true	Inferred relationship	Existential restriction modifier	1
Product containing natalizumab	Is a	Inflammatory bowel disease drug	false	Inferred relationship	Existential restriction modifier
Product containing natalizumab	Is a	Product containing murine-human monoclonal immunoglobulin G antibody	false	Inferred relationship	Existential restriction modifier
Product containing natalizumab	Is a	Product containing immunomodulator	true	Inferred relationship	Existential restriction modifier
Product containing natalizumab	Is a	Virtual therapeutic moiety	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Natalizumab 300mg injection solution 15mL vial	Is a	False	Product containing natalizumab	Inferred relationship	Existential restriction modifier
Product containing precisely natalizumab 300 milligram/15 milliliter conventional release solution for injection vial	Is a	False	Product containing natalizumab	Inferred relationship	Existential restriction modifier
Product containing natalizumab in parenteral dose form (medicinal product form)	Is a	True	Product containing natalizumab	Inferred relationship	Existential restriction modifier
Natalizumab	Is a	True	Product containing natalizumab	Inferred relationship	Existential restriction modifier
Natalizumab 150mg/1ml solution for injection pre-filled syringes	Is a	False	Product containing natalizumab	Inferred relationship	Existential restriction modifier
Natalizumab 300mg/15ml solution for infusion vials	Is a	False	Product containing natalizumab	Inferred relationship	Existential restriction modifier
Natalizumab 300mg/15ml solution for infusion vials	Is a	False	Product containing natalizumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets